A01N43/44

HERBICIDAL PHENYLPYRIDINES

The present invention relates to phenylpyridines of formula (I)

##STR00001##

wherein the variables are defined according to the description, processes and intermediates for preparing the phenylpyridines of the formula (I), compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one phenylpyridine of the formula (I) to act on plants, their seed and/or their habitat.

HERBICIDAL PHENYLPYRIDINES

The present invention relates to phenylpyridines of formula (I)

##STR00001##

wherein the variables are defined according to the description, processes and intermediates for preparing the phenylpyridines of the formula (I), compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one phenylpyridine of the formula (I) to act on plants, their seed and/or their habitat.

METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION

The invention provides a method for inactivation or reduction of pathogens, microorganisms or parasites in a sample, media, composition, utility, device, surface or organism by treatment with an alkylating compound of Structure I, followed by elimination or reduction of the residual compound with Structure I by treatment with a neutralizing agent, which eliminates or reduces the toxicity or other undesirable properties of the alkylating compound with Structure I. The neutralizing agent may be present in a treatment solution or be part of a solid-phase agent, and preferably acts by eliminating the alkylating properties of the compound of Structure I.

METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION

The invention provides a method for inactivation or reduction of pathogens, microorganisms or parasites in a sample, media, composition, utility, device, surface or organism by treatment with an alkylating compound of Structure I, followed by elimination or reduction of the residual compound with Structure I by treatment with a neutralizing agent, which eliminates or reduces the toxicity or other undesirable properties of the alkylating compound with Structure I. The neutralizing agent may be present in a treatment solution or be part of a solid-phase agent, and preferably acts by eliminating the alkylating properties of the compound of Structure I.

USE AS RODENTICIDES OF COMPOUNDS THAT INHIBIT BLOOD COAGULATION
20170127667 · 2017-05-11 ·

The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.

USE AS RODENTICIDES OF COMPOUNDS THAT INHIBIT BLOOD COAGULATION
20170127667 · 2017-05-11 ·

The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.

USE AS RODENTICIDES OF COMPOUNDS THAT INHIBIT BLOOD COAGULATION
20170127667 · 2017-05-11 ·

The invention relates to a use, a method and a poison in which a thrombin inhibitor, a thrombin receptor antagonist, a factor Xa inhibitor, a PAI (plasminogen activator inhibitor), a P2Y12 ADP receptor antagonist or a GPIIb/IIIa receptor antagonist are used as rodenticide.

Stabilization of compounds comprising iodine

Use of aziridines for stabilizing iodine-containing compounds, especially biocides.

Stabilization of compounds comprising iodine

Use of aziridines for stabilizing iodine-containing compounds, especially biocides.

METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION

The invention provides a method for inactivation or reduction of pathogens, microorganisms or parasites in a sample, media, composition, utility, device, surface or organism by treatment with an alkylating compound of Structure I, followed by elimination or reduction of the residual compound with Structure I by treatment with a neutralizing agent, which eliminates or reduces the toxicity or other undesirable properties of the alkylating compound with Structure I. The neutralizing agent may be present in a treatment solution or be part of a solid-phase agent, and preferably acts by eliminating the alkylating properties of the compound of Structure I.